{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:28:03Z","timestamp":1790962083733,"version":"4.1.0"},"reference-count":41,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2022,1,25]]},"DOI":"10.1253\/circj.cj-21-0631","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T22:08:39Z","timestamp":1638223719000},"page":"202-210","source":"Crossref","is-referenced-by-count":8,"title":["Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation\u3000\u2015 Substudy of the ANAFIE Registry \u2015"],"prefix":"10.1253","volume":"86","author":[{"given":"Takanori","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Atarashi","sequence":"additional","affiliation":[{"name":"AOI Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Koretsune","sequence":"additional","affiliation":[{"name":"National Hospital Organization Osaka National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Osaka Police Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine and Neurology, Cerebrovascular Center, National Hospital Organization Kyushu Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Medical Science Department, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Kaburagi","sequence":"additional","affiliation":[{"name":"ASCA Company, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takita","sequence":"additional","affiliation":[{"name":"Data Intelligence Department, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Saiseikai Toyama Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Martinez C, Katholing A, Wallenhorst C, Granziera S, Cohen AT, Freedman SB. Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. <i>Heart<\/i> 2015; 101: 1748\u20131754.","DOI":"10.1136\/heartjnl-2015-307808"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. <i>Int J Cardiol<\/i> 2009; 137: 102\u2013107.","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). <i>Eur Heart J<\/i> 2010; 31: 2369\u20132429.","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in <i>CA Cancer J Clin<\/i> 2020; <b>70:<\/b> 313]. <i>CA Cancer J Clin<\/i> 2018; 129: 837\u2013847.","DOI":"10.3322\/caac.21492"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: A potentially modifiable relationship. <i>Am J Prev Med<\/i> 2014; 46(3 Suppl 1): S7\u2013S15.","DOI":"10.1016\/j.amepre.2013.10.029"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study. <i>Circulation<\/i> 2014; 129: 837\u2013847.","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jakobsen CB, Lamberts M, Carlson N, Lock-Hansen M, Torp-Pedersen C, Gislason GH, et al. Incidence of atrial fibrillation in different major cancer subtypes: A nationwide population-based 12 year follow up study. <i>BMC Cancer<\/i> 2019; 19: 1105.","DOI":"10.1186\/s12885-019-6314-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. <i>Thromb Res<\/i> 2017; 155: 101\u2013105.","DOI":"10.1016\/j.thromres.2017.05.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Vinter N, Christesen AMS, Fenger-Gr\u00f8n M, Tj\u00f8nneland A, Frost L. Atrial fibrillation and risk of cancer: A Danish population-based cohort study. <i>J Am Heart Assoc<\/i> 2018; 7: e009543.","DOI":"10.1161\/JAHA.118.009543"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chu G, Versteeg HH, Verschoor AJ, Trines SA, Hemels MEW, Ay C, et al. Atrial fibrillation and cancer: An unexplored field in cardiovascular oncology. <i>Blood Rev<\/i> 2019; 35: 59\u201367.","DOI":"10.1016\/j.blre.2019.03.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ruigomez A, Johansson S, Wallander MA, Edvardsson N, Garcia Rodriguez LA. Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis. <i>Int J Cardiol<\/i> 2009; 136: 186\u2013192.","DOI":"10.1016\/j.ijcard.2008.04.050"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zaorsky NG, Zhang Y, Tchelebi LT, Mackley HB, Chinchilli VM, Zacharia BE. Stroke among cancer patients. <i>Nat Commun<\/i> 2019; 10: 5172.","DOI":"10.1038\/s41467-019-13120-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. <i>Blood<\/i> 2013; 122: 1712\u20131723.","DOI":"10.1182\/blood-2013-04-460121"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Khorana AA. Venous thromboembolism and prognosis in cancer. <i>Thromb Res<\/i> 2010; 125: 490\u2013493.","DOI":"10.1016\/j.thromres.2009.12.023"},{"key":"15","unstructured":"15. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al; American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. <i>J Am Coll Cardiol<\/i> 2014; 64: e1\u2013e76."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. <i>Eur Heart J<\/i> 2016; 37: 2893\u20132962.","DOI":"10.5603\/KP.2016.0172"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nishimoto Y, Yamashita Y, Kim K, Morimoto T, Saga S, Amano H, et al. Risk factors for major bleeding during anticoagulation therapy in cancer-associated venous thromboembolism: From the COMMAND VTE registry. <i>Circ J<\/i> 2020; 84: 2006\u20132014.","DOI":"10.1253\/circj.CJ-20-0223"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology: Atrial fibrillation in cancer. <i>J Am Coll Cardiol<\/i> 2014; 63: 945\u2013953.","DOI":"10.1016\/j.jacc.2013.11.026"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fanola CL, Ruff CT, Murphy SA, Murphy SA, Jin J, Duggal A, et al. Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: Analysis of the ENGAGE AF-TIMI 48 trial. <i>J Am Heart Assoc<\/i> 2018; 7: e008987.","DOI":"10.1161\/JAHA.118.008987"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, et al. Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: Insights from the ARISTOTLE trial. <i>Am J Med<\/i> 2017; 130: 1440\u20131448.e1.","DOI":"10.1016\/j.amjmed.2017.06.026"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yang P, Zhu D, Xu X, Shen W, Wang C, Jiang Y, et al. Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer: A network meta-analysis. <i>Heart Fail Rev<\/i> 2020; 25: 823\u2013831.","DOI":"10.1007\/s10741-019-09844-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation [published correction appears in <i>N Engl J Med<\/i> 2010; <b>363:<\/b> 1877]. <i>N Engl J Med<\/i> 2009; 361: 1139\u20131151.","DOI":"10.1056\/NEJMoa0905561"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 883\u2013891.","DOI":"10.1056\/NEJMoa1009638"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 981\u2013992.","DOI":"10.1056\/NEJMoa1107039"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2013; 369: 2093\u20132104.","DOI":"10.1056\/NEJMoa1310907"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shah S, Norby FL, Datta YH, Lutsey PL, MacLehose RF, Chen LY, et al. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. <i>Blood Adv<\/i> 2018; 2: 200\u2013209.","DOI":"10.1182\/bloodadvances.2017010694"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Koretsune Y, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Baseline demographics and clinical characteristics in the All Nippon AF in the Elderly (ANAFIE) registry [published correction appears in <i>Circ J<\/i> 2020; <b>84:<\/b> 360]. <i>Circ J<\/i> 2019; 83: 1538\u20131545.","DOI":"10.1253\/circj.CJ-19-0094"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Inoue H, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry. <i>J Cardiol<\/i> 2018; 72: 300\u2013306.","DOI":"10.1016\/j.jjcc.2018.02.018"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sakamoto J, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, et al. Cancer-associated venous thromboembolism in the real world: From the COMMAND VTE Registry. <i>Circ J<\/i> 2019; 83: 2271\u20132281.","DOI":"10.1253\/circj.CJ-19-0515"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, et al. Clinical impact of bleeding in cancer-associated venous thromboembolism: Results from the Hokusai VTE Cancer study. <i>Thromb Haemost<\/i> 2018; 118: 1439\u20131449.","DOI":"10.1055\/s-0038-1667001"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yasui T, Shioyama W, Oboshi M, Oka T, Fujita M. Oral anticoagulants in Japanese patients with atrial fibrillation and active cancer. <i>Intern Med<\/i> 2019; 58: 1845\u20131849.","DOI":"10.2169\/internalmedicine.2415-18"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yamashita Y, Uozumi R, Hamatani Y, Esato M, Chun YH, Tsuji H, et al. Current status and outcomes of direct oral anticoagulant use in real-world atrial fibrillation patients: Fushimi AF registry. <i>Circ J<\/i> 2017; 81: 1278\u20131285.","DOI":"10.1253\/circj.CJ-16-1337"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Kuronuma K, Oiwa K, et al. Three-year clinical outcomes associated with warfarin vs. direct oral anticoagulant use among Japanese patients with atrial fibrillation: Findings from the SAKURA AF registry. <i>Circ J<\/i> 2018; 82: 2500\u20132509.","DOI":"10.1253\/circj.CJ-18-0535"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, et al. Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: Findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. <i>Circulation<\/i> 2015; 132: 624\u2013632.","DOI":"10.1161\/CIRCULATIONAHA.114.014807"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kato ET, Giugliano RP, Ruff CT, Koretsune Y, Yamashita T, Kiss RG, et al. Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. <i>J Am Heart Assoc<\/i> 2016; 5: e003432.","DOI":"10.1161\/JAHA.116.003432"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. O\u2019Neal WT, Lakoski SG, Qureshi W, Judd SE, Howard G, Howard VJ, et al. Relation between cancer and atrial fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study). <i>Am J Cardiol<\/i> 2015; 115: 1090\u20131094.","DOI":"10.1016\/j.amjcard.2015.01.540"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hanigan S, Das J, Pogue K, Barnes GD, Dorsch MP. The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding. <i>J Thromb Thrombolysis<\/i> 2020; 49: 636\u2013643.","DOI":"10.1007\/s11239-020-02037-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Akbulut M, Urun Y. Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs. <i>Crit Rev Oncol Hematol<\/i> 2020; 145: 102822.","DOI":"10.1016\/j.critrevonc.2019.102822"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Mazurek M, Lip GYH. Gastrointestinal bleeding and direct oral anticoagulants amongst patients with atrial fibrillation in the \u201creal world\u201d. <i>Gastroenterology<\/i> 2017; 152: 932\u2013934.","DOI":"10.1053\/j.gastro.2017.02.027"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Laine L. Bleeding with direct oral anticoagulants: The gastrointestinal tract and beyond. <i>Clin Gastroenterol Hepatol<\/i> 2017; 15: 1665\u20131667.","DOI":"10.1016\/j.cgh.2017.06.041"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Miller CS, Dorreen A, Martel M, Huynh T, Barkun AN. Risk of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants: A systematic review and meta-analysis. <i>Clin Gastroenterol Hepatol<\/i> 2017; 15: 1674\u20131683.e3.","DOI":"10.1016\/j.cgh.2017.04.031"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/2\/86_CJ-21-0631\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T03:53:13Z","timestamp":1643428393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/2\/86_CJ-21-0631\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-21-0631","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"article-number":"CJ-21-0631"}}